NCT05605379View on ClinicalTrials.gov

CML Pediatric ITK Response According to Molecular Identification at Diagnosis

RecruitingOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Chronic Myeloid Leukemia
Interventions
BIOLOGICAL

Next Generation Sequencing (DNA and RNA)

Targeted Next Generation Sequencing (DNA and RNA)

Trial Locations (1)

Unknown

RECRUITING

CHU de Bordeaux, Service Hématologie Biologique, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER